347 related articles for article (PubMed ID: 32366182)
1. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications.
Voigtländer T; Jaeckel E; Lehner F; Manns MP; Lankisch TO
Liver Transpl; 2015 Oct; 21(10):1295-9. PubMed ID: 26069199
[TBL] [Abstract][Full Text] [Related]
4. Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases.
Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Eurich D; Faber W; Neuhaus P; Seehofer D
Medicine (Baltimore); 2015 Dec; 94(49):e2188. PubMed ID: 26656347
[TBL] [Abstract][Full Text] [Related]
5. Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.
Leonhardt S; Veltzke-Schlieker W; Adler A; Schott E; Hetzer R; Schaffartzik W; Tryba M; Neuhaus P; Seehofer D
Crit Care; 2015 Mar; 19(1):131. PubMed ID: 25886728
[TBL] [Abstract][Full Text] [Related]
6. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
7. Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis.
Voigtländer T; Leuchs E; Vonberg RP; Solbach P; Manns MP; Suerbaum S; Lankisch TO
J Infect; 2015 May; 70(5):483-90. PubMed ID: 25659761
[TBL] [Abstract][Full Text] [Related]
8. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
9. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
10. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis: liver transplantation or biliary surgery.
Farges O; Malassagne B; Sebagh M; Bismuth H
Surgery; 1995 Feb; 117(2):146-55. PubMed ID: 7846618
[TBL] [Abstract][Full Text] [Related]
12. Secondary sclerosing cholangitis following major burn.
Ben-Ari Z; Levingston D; Weitzman E; Haviv-Yadid Y; Cohen-Ezra O; Weiss P; Zuckerman E; Inbar Y; Amitai M; Rimon U; Goder M; Haik J
Ann Hepatol; 2015; 14(5):695-701. PubMed ID: 26256898
[TBL] [Abstract][Full Text] [Related]
13. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis.
Hilscher M; Enders FB; Carey EJ; Lindor KD; Tabibian JH
Ann Hepatol; 2016; 15(2):246-53. PubMed ID: 26845602
[TBL] [Abstract][Full Text] [Related]
14. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis.
Gossard AA; Angulo P; Lindor KD
Am J Gastroenterol; 2005 Jun; 100(6):1330-3. PubMed ID: 15929765
[TBL] [Abstract][Full Text] [Related]
15. Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course.
Campsen J; Zimmerman MA; Trotter JF; Wachs M; Bak T; Steinberg T; Kam I
Liver Transpl; 2008 Feb; 14(2):181-5. PubMed ID: 18236392
[TBL] [Abstract][Full Text] [Related]
16. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
17. Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome.
Voigtländer T; Negm AA; Schneider AS; Strassburg CP; Manns MP; Wedemeyer J; Lankisch TO
Endoscopy; 2012 Nov; 44(11):1055-8. PubMed ID: 23108773
[TBL] [Abstract][Full Text] [Related]
18. Severity of primary sclerosing cholangitis and its impact on the clinical outcome of Crohn's disease.
Navaneethan U; G K Venkatesh P; Lashner BA; Lopez R; Kiran RP; Shen B
J Crohns Colitis; 2012 Jul; 6(6):674-80. PubMed ID: 22398102
[TBL] [Abstract][Full Text] [Related]
19. The impact of ulcerative colitis on the long-term outcome of patients with primary sclerosing cholangitis.
Navaneethan U; Venkatesh PG; Lashner BA; Shen B; Kiran RP
Aliment Pharmacol Ther; 2012 May; 35(9):1045-53. PubMed ID: 22428605
[TBL] [Abstract][Full Text] [Related]
20. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Bossen L; Vesterhus M; Hov JR; Färkkilä M; Rosenberg WM; Møller HJ; Boberg KM; Karlsen TH; Grønbæk H
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00315. PubMed ID: 33646203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]